A California-based marijuana company is preparing for its Canadian listing after waiting for the end of the grueling summer months.
On Friday (November 1), ManifestSeven issued a letter to investors indicating it will take the final steps for its public listing on the Canadian Securities Exchange (CSE); it was originally planned for September.
The company held off because a variety of critical developments for the marijuana investing space did not arrive until later in the year, including the legalization of edible and infused products in Canada and the passing of the SAFE Banking Act by US Congress.
In the letter to investors, ManifestSeven Director and CEO Sturges Karban said the company is now working to update its original initial application form — which was filed with the CSE in May — since the company has advanced its position from earlier in the year.
Karban said the company anticipates approval of its application within a few weeks from official filing.
The executive said ManifestSeven was initially aiming to file its application right after the Labor Day holiday in the US when, according to him, “the global markets would presumably begin reemerging from their seasonal inertia.” Ultimately the firm decided to wait.
Despite the state of the investment landscape for marijuana plays, Karban said he is excited about the position his company is in.
“Upon surveying and analyzing the most distressed publicly-traded cannabis companies today, it is evident that almost all the recent fallout in the marketplace has resulted from self-inflicted and avoidable problems that are not applicable in the case of (ManifestSeven),” he said.
According to the executive, these issues in the market include: persistent undercapitalization, reckless cost structures (usually inclusive of excessive executive compensation) and onerous financing transactions.
ManifestSeven made headlines recently after it commissioned a study on sentiment surrounding marijuana stocks from high-end investors.
The report indicates a high level of confidence from current investors about their chances of making back their money based on the state of the market.
“Investors are seeing the industry’s first major market correction,” said Karban. “And yet, 71 percent of retail investors in the US and 73 percent in Canada say they expect investment in the cannabis industry to significantly grow over the next 12 months.”
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).